An interventional study of exercise and vitamin D intake and vitamin D intake in Diabetes Mellitus, Erectile Dysfunction and Vitamin D Deficiency, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to male participants aged 35 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-01-26.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Among 36 studies in Diabetes Mellitus by Cairo University — 7 open to participants now, 9 under way, none of them phase 3. Diabetes Mellitus · Cairo University.
Among the 36 studies in Diabetes Mellitus by Cairo University, this one is the 21st largest by planned enrollment of the 26 interventional ones that give a count, is one of 2 that started in 2025, is one of 24 with no phase, and was the 32nd registered.
8,291 studies on the registry are indexed under Diabetes Mellitus; 1,075 are open to participants now.
Browse Diabetes Mellitus studies →7 of the 36 studies in Diabetes Mellitus by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 65–70 · Women only
Cairo University · Sites in Egypt
Ages 50–60 · Men only
Cairo University · Sites in Egypt
Ages 65–75
Cairo University
Ages 18+
Cairo University
Ages 20+ · Healthy volunteers
By country, each count listing its studies:
Of the 649 Diabetes Mellitus studies recruiting now, 357 (55%) set no upper age limit and 197 (30%) stop at 75 or younger; 88 take children under 18; 183 take healthy volunteers.
This study: 35 Years to 45 Years · male · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
36 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 80 across 6,024 interventional studies indexed under Diabetes Mellitus.
Median enrollment 53 across the 26 interventional studies, 104 across the 10 observational. Of the 14 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,941 studies on the registry; 1,457 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
2 of the studies in Diabetes Mellitus by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07858604Cairo UniversityAwareness of Bidirectional Relation of Diabetes Mellitus and Periodontal Health | 2027-10 |
| NCT07776535Cairo UniversityEffects Of Otago Exercise Versus Multisensory Integration Training On Balance And Gait In Elderly With Diabetes | 2027-10 |
Add all 2 to your calendar (.ics) → With an account.
Among the 36 studies in Diabetes Mellitus by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
males with diabetes complain impotence in the presence of low vitamin D deficiency. pharacmological treatment of low vitamin D levels is necessary but changing lifestyle by performing exercise is also important
forty diabetic men (type 2) who complain presence of low vitamin D and impotence will be divided to group number I and group number II. Both groups will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.
Behavioral: exercise and vitamin D intake
twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks.
Other: vitamin D intake
twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks. Additionally, Group number I will perform treadmill walking (one hour walking) with moderate intensity. This walking will be performed three times per designed week for twelve weeks.
twenty diabetic men (type 2) who complain presence of low vitamin D and impotence will be pharmacologically treated by administration of Cholecalciferol 200.000 I.U (will be taken every two weeks). this treatment will last for 12 weeks.
international index of erectile function
questionnaire used to assess impotence
Time frame: it will be measured after 12 weeks
glycated hemoglubin
it will be used to assess blood glcuose
Time frame: It will be measured after 12 weeks
fasting blood glcuose
it will be used to assess blood glcuose in serum
Time frame: It will be measured after 12 weeks
body mass index
it will be measured on empty stomach and bladder
Time frame: It will be measured after 12 weeks
wasit circumference
it will be measured at umbilicus level
Time frame: it will be measured after 12 weeks
high density lipoprotein
it will be measured in serum
Time frame: It will be measured after 12 weeks
low density lipoprotein
it will be measured in serum
Time frame: It will be measured after 12 weeks
triglycerides
it will be assessed in serum
Time frame: It will be measured after 12 weeks
cholesterol
it will be assessed in serum
Time frame: It will be measured after 12 weeks
25-hydroxyvitamin D
it will be assessed in serum as a metabolite of vitamin D
Time frame: It will be measured after 12 weeks
Started Dec 2025 (actual). Primary completion is estimated for May 2026, 5 months after the start.
Of 1,584 non-industry interventional studies with no phase under Diabetes Mellitus, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 5 months is below that.
Counting every sponsor, half of 1,744 studies reached it within 21 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.